Auvelity Insurance Denied? How to Appeal Your Dextromethorphan/Bupropion Denial

Auvelity (dextromethorphan/bupropion) is a first-in-class oral antidepressant FDA-approved for major depressive disorder (MDD) in adults. Its unique mechanism — NMDA receptor antagonism combined with sigma-1 receptor agonism — is shared with esketamine but delivered as a convenient oral tablet rather than requiring in-clinic administration. Despite its novel mechanism and FDA approval, insurance companies frequently deny Auvelity due to step therapy requirements and formulary preferences for older, cheaper antidepressants. Here's how to appeal.

What Auvelity Treats and Why Patients Need It

Auvelity combines dextromethorphan (DXM), an NMDA receptor antagonist and sigma-1 agonist, with bupropion. Bupropion serves two purposes: it provides some antidepressant effect of its own, and it inhibits the metabolism of DXM, allowing therapeutic plasma levels to be achieved with oral dosing.

This mechanism targets glutamate signaling, which is increasingly recognized as a key driver of depression. Unlike serotonin-based antidepressants that require weeks for onset, Auvelity demonstrated statistically significant improvements in depression symptoms as early as week 1 in clinical trials.

In the GEMINI Phase 3 trial:

• Patients on Auvelity showed significant reduction in MADRS (Montgomery-Asberg Depression Rating Scale) scores versus placebo
• 43% of patients achieved response (≥50% improvement in MADRS) at week 6
• Onset of effect was apparent at week 1, earlier than typical SSRIs/SNRIs

For patients who have tried and failed conventional antidepressants, Auvelity offers a different pharmacological pathway that may succeed where serotonin-based agents failed — in a convenient, at-home oral form.

Common Denial Reasons for Auvelity

Step therapy requirements: Insurers routinely require failure of multiple first-line antidepressants (SSRIs, SNRIs) before approving Auvelity. Common thresholds are two or more failed adequate trials.

Formulary exclusion: As a newer branded drug, Auvelity may not be on the plan's formulary at all, or may be on a non-preferred specialty tier with prohibitive cost-sharing.

Preferred antidepressant not tried: Plans may require trials of generic SSRIs (sertraline, escitalopram) and SNRIs (venlafaxine, duloxetine) before considering novel mechanisms.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not submitted or incomplete: Missing diagnosis, severity documentation (PHQ-9), or prior treatment history.

Cost-effectiveness argument: Insurers may argue that generic antidepressants provide equivalent benefit, ignoring the mechanistic difference and the reality that many patients are treatment-refractory.

Step-by-Step: How to Appeal an Auvelity Denial

Step 1: Identify the denial reason. Step therapy? Formulary exclusion? Missing prior auth?

Step 2: Document your antidepressant history. For each prior antidepressant: drug, dose, duration (in weeks at therapeutic dose), and outcome. This is the core evidence for step therapy appeals.

Step 3: Quantify your current depression severity. PHQ-9, MADRS, or other validated scoring. Moderate-to-severe ongoing depression despite trials of multiple agents builds the medical necessity case.

Step 4: Have your psychiatrist or prescriber write a Letter of Medical Necessity documenting your MDD diagnosis, prior treatment failures, current symptom burden, and why Auvelity is the appropriate next step given its novel mechanism.

Step 5: Document any contraindications to further SSRI/SNRI trials. Adverse effects like sexual dysfunction, weight gain, GI intolerance, serotonin syndrome risk, or prior treatment-emergent adverse effects can support departing from serotonin-based agents.

Step 6: File the internal appeal with all documentation and request peer-to-peer review.

Step 7: File an external appeal if the internal appeal is denied. Mental health parity laws may apply.

What to Include in Your Auvelity Appeal Letter

• Policy number, member ID, and claim reference
• Auvelity (dextromethorphan/bupropion HBr) dose and indication
• PHQ-9 or MADRS score showing current depression severity
• Prior antidepressant history: drug, dose, duration, outcome
• Documentation of any augmentation strategies tried
• Contraindications or adverse effects to prior antidepressants
• Letter of Medical Necessity from psychiatrist or prescribing physician
• GEMINI trial citation and FDA approval reference (October 2022)
• Mental health parity arguments if applicable
• Request for peer-to-peer review

Success Tips for Auvelity Appeals

Show treatment history clearly. The most common step therapy threshold for Auvelity is two failed adequate antidepressant trials. If you've tried two or more SSRIs or SNRIs at appropriate doses for sufficient duration, document this point by point and your appeal should meet the standard.

Highlight the novel mechanism argument. Auvelity works through NMDA receptor antagonism — a glutamatergic mechanism different from every SSRI, SNRI, and tricyclic antidepressant on the formulary. Patients who fail multiple serotonin-based agents are candidates for a mechanistically distinct approach. Your psychiatrist can articulate this in the LMN.

Document early onset benefit. Many depression patients have been suffering for months or years through medication trials. The evidence that Auvelity works as early as week 1 is clinically meaningful for patients who need faster relief, particularly in the context of functional impairment, work disability, or safety concerns.

Invoke mental health parity. Under MHPAEA, mental health step therapy requirements that are more restrictive than what's applied to comparable medical conditions may constitute a parity violation. Consult a patient advocate if you suspect parity violations.

Fight Back With ClaimBack

Major depression deserves treatment that works. When the same antidepressants keep failing, Auvelity offers a genuinely different approach. If your insurer denied it, ClaimBack can help you fight back with a complete, persuasive appeal.

Start your Auvelity appeal at ClaimBack

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs. External Insurance Appeals